Though generative AI could make game development faster and easier, the industry is divided on where AI fits into the picture.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Arch Resources and Consol Energy announced plans for a merger to create a new $5.2 billion coal giant called Core Natural Resources.
Both Target and TJ Maxx posted stellar earnings results on the strength of the incredibly resilient US consumer.
Antitrust regulators in India flagged Disney’s $8.5 billion merger with Reliance for competition concerns in cricket broadcast rights.
The European Commission on Tuesday solidified new tariffs for electric vehicles imported from China. The actual numbers aren’t harsh.
GM is cutting over 1,000 workers, equivalent to roughly 1.3% of its total workforce, from its software and services division.
Functional beverages — drinks producers tout as having health benefits because they have been infused with bioactive compounds.
After nearly 3,000 years, the business of the Olympics is ripe for disruption. Could performance enhancing drugs shake up the games?
The World Health Organization has declared mpox to be a public health emergency, and pharmaceutical and healthcare winners have emerged.
But data aside, many have cast doubt on the company’s plan for autonomous ridesharing.
Mars announced on Wednesday that it has agreed to buy snack maker Kellanova, a spin-off from Kellogg’s, for a mouth-watering $35.9 billion.
For Starbucks chief Laxman Narasimhan, the daily grind is over. The embattled coffee chain named Chipotle CEO Brian Niccol his successor.
As Paramount moves under the control of Skydance Media, current leadership is undergoing a campaign to realize half a billion in savings.
Airbus hasn’t been able to capitalize much on Boeing’s misfortunes thanks to its own workforce and supply chain issues.
As the ISS is decommissioned, several space station projects are in the works, but a business model may be the final frontier.
Novo Nordisk’s share price fell over 8% on Wednesday after the company reported lower-than-expected sales of Wegovy.